Updated guidance on metal-on-metal (MoM) hip replacements

 

The Medicines and Healthcare products Regulatory Agency (MHRA) as a precautionary measure has  issued updated guidance for healthcare professionals who manage patients implanted with metal-on-metal hip replacements. You can find out more here:

Updated guidance

Previous guidance was issued to ensure appropriate follow-up to monitor the potential for the already well-known risks of soft-tissue reactions. This updated guidance replaces the previous advice provided in 2012.

 July 2017